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Abstract
Meningococcal disease is a life-threatening illness with
annual incidence rates varying from 1 to 1000 per 100
000 persons in different parts of the world. Effective
polysaccharide and polysaccharide-protein conjugate
vaccines that offer protection against infection with
meningococcal serogroups A, C, Y and W-135 have been
licensed and are available worldwide. Serogroup B re-
mains the most prevalent cause of meningococcal dis-
ease responsible for 32% of all meningococcal disease
in the United States, 45 to 80% of the cases in Europe,
and for the majority of cases in the rest of the world. The
development of a vaccine against serogroup B poses the
biggest problem due to the similarity between the B cap-
sular polysaccharide structure and a polysialic acid con-
taining glycopeptides that are a part of human brain tis-
sue. Prevention of meningococcal disease will require
the development of an effective vaccine to combat
serogroup B, which is the cause of most meningococcal
cases in developed countries. The availability of the com-
plete sequence information of Neisseria meningitides
serogroup B proteome has made it possible to carry out
the in silico analysis of its genome for identification of
potential vaccine and drug targets. Our study revealed
1413 proteins which are non-homologous to human ge-
nome. Screening these proteins using the Database of
Essential Genes (DEG) resulted in the identification of
362 proteins as essential proteins of the bacterium. Analy-
sis of the identified essential proteins, using the KEGG
Automated Annotation Server (KAAS) housed at Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways
database, revealed 35 enzymes of N. Meningitides  that
may be used as potential drug targets, as they belongs to
pathways present only in the bacterium and not present
in humans. Subcelluler localization prediction of these
essential proteins revealed that 9 proteins lie on the outer
membrane of the pathogen which could be potential vac-
cine targets. Screening of the functional inhibitors against
these novel targets may result in discovery of novel thera-
peutic compounds that can be effective against Neisseria
meningitides Serogroup B.
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Introduction
Despite rapid advances in the diagnosis of bacterial infections
and the availability of effective antibiotics, meningococcal disease
continues to represent a substantial public health problem for most
countries (Tzeng et al., 2000).  N. meningitides is a Gram-negative
bacterium that colonizes asympto matically the upper nasopharinx
tract of about 5–15% of human population. The bacterium can
traverse the epithelium and reach the blood stream causing septice-
mia. From the blood meningococcus is able to cross the blood brain
barrier and infect the meninges, causing meningitis potentially lead-
ing to shock and death (van et al., 2000; Stephens et al., 2007).
95% of total cases of meningitis are caused by five major serogroups:
A, B, C, Y and W135. Vaccines against serogroups A, C, Y and
W135 were developed in the 1960s by using the purified capsular
polysaccharide as antigen. In the last 40 years a lot of efforts have
been directed to the identification of meningococcus B antigens as
basis of new vaccines. However, the high variability of these pro-
teins among the different MenB strains represents a serious ob-
stacle to the production of a globally effective anti-MenB vaccine
(Stephens et al., 2007).
Till date the complete genome sequence of about 863 bacteria
has been determined and 1653 bacterial genome projects are cur-
rently in progress. Availability of genome sequences of pathogens
has provided a tremendous amount of information that can be use-
ful in drug target and vaccine target identification.  Any gene vital
to sustain life and cellular growth of pathogenic organism may be a
possible drug target, particularly when the sequence of that gene
has little or no similarity to those of the host organism. The differ-
ences in the proteins of the host and the pathogen can be effectively
used for designing a drug specifically targeting the pathogen. The
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application of in silico subtractive genomics technology signifi-
cantly shortens the time required both for identification of antigens
and their utility as protective immunogen. Subtractive genomics
help enables the subtraction dataset between the host and pathogen
genome and provides information for a set of genes that are likely
to be essential to the pathogen but absent in the host. This approach
has been used successfully to identify essential genes in Pseudomo-
nas aeruginosa (Sakharkar et al., 2004; Perumal et al., 2007). Same
methodology was implemented by us for the analysis of the whole
proteome sequence of the human pathogen Neisseria meningitides
Serogroup B.
The current studies makes use of the subtractive genomics ap-
proach, database of essential gene (DEG), differential pathway
analysis and sub cellular localization prediction to analyze the com-
plete proteome of N. meningitides serogroup B to search for poten-
tial drug and vaccine targets.
Methodology
The essential proteins in N.  meningitides serogroup B were iden-
tified using subtractive genomics approach and further analyzed
for identification of potential drug targets. The flow chart describ-
ing the detailed methodology for identifying of pathogen specific
essential proteins using subtractive genomics approach is mentioned
in figure 1.
Retrieval of Proteomes of Host and Pathogen
The complete proteome of  N. meningitides serogroup B was
retrieved from SwissProt (Bairoch et al., 2000) and complete Homo
sapiens proteome was downloaded from NCBI (Maglott et al.,
2007). Prokaryotic essential protein sequences were retrieved from
the database of essential genes (DEG) (Zhang et al., 2004) from its
location http://tubic.tju.edu.cn/deg/ by using an in-house designed
perl script.
Identification of Essential Proteins in N. Meningitidis
N.  Meningitides Serogroup B proteome was purged at 60%
threshold using CD-HIT (Li et al., 2006) to exclude paralogs or
duplicates for further analysis. The set of proteins obtained were
subjected to BlastP against Homo sapiens proteome with the ex-
pectation value (E-value) cutoff of 10-4. An in-house designed perl
script was used to retrieve the protein sequences of N. Meningiti-
des serogroup B showing no significant similarity with Homo sa-
piens proteome. BlastP analysis was performed for the non ho-
mologous protein sequences of N. meningitides serogroup B against
database of essential proteins retrieved from DEG with E-value
cutoff score of 10-10 and 30% identity. A minimum bit-score cut-off
of 100 was used to screen out proteins that appeared to represent
essential genes. The protein sequences obtained are non homolo-
gous essential proteins of N. meningitides serogroup B.
Stand-alone BLAST software (ftp://ftp.ncbi.nlm.nih.gov/blast/
executables/LATEST/blast-2.2.21-ia32-win32.exe) was used for the
BlastP analysis. E-value cutoff threshold for BlastP and DEG search
were set by using the command line parameters option in stand-
alone BLAST.
Functional Classification of the Uncharacterized Essential Pro-
teins
Functional family prediction of the putative uncharacterized es-
sential proteins was done by using the SVMProt web server (http:/
/jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi.) (Cai et al., 2003).
SVMProt utilizes Support Vector Machine for classification of a
protein into functional family from its primary sequence.
Metabolic Pathway Analysis
Metabolic pathway analysis of the essential proteins of N. men-
ingitides was done by KEGG Automatic Annotation Server (KAAS)
(Moriya et al., 2007). Comparative analysis of the metabolic path-
ways of the host and pathogen was performed by using Kyoto En-
cyclopedia of Genes and Genomes (KEGG) pathway database
(Kanehisa et al., 2000) to trace out essential proteins involved in
pathogen specific metabolic pathways for the identification of po-
tential drug targets.
Sub Cellular Localization Prediction
Sub-cellular localization analysis of the essential proteins has
been done by Proteome Analyst Specialized Sub Cellular Local-
ization Server v2.5 (PA-SUB) (Lu et al., 2004) to identify the sur-
Figure 1: Flowchart for identification of essential proteins in
N. meningitides Serogroup B.
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face membrane proteins which could be probable vaccine targets.
Results and Discussion
N. meningitides serogroup B proteome was found to contain 2001
proteins. Out of these, 1939 non-paralogs sequences were retrieved
by using CD-HIT program at 60% identity. All the proteins of N.
meningitides that are non-homologous to the human proteome could
not be taken directly as targets as these also include a large number
of proteins which are not essential for the viability of the organism.
Therefore, out of 1939 proteins, 1413 proteins were identified as
non-homologues to the human proteome and were subjected to
BLASTP against DEG with E-value cutoff score of 10-10 and 30%
identity. 362 proteins comprising 18% of the total number of pro-
tein coding sequences in N. meningitides serogroup B found to be
essential. Detailed analysis of  N. meningitides serogroup B
proteome is mentioned in supplementary table 1.
Functional classification of the 36 putative uncharacterized es-
sential proteins was performed by using the SVMProt web server
based on P value, which is the expected classification accuracy in
terms of percentage.  10 proteins were classified as transmembrane
proteins , 6 as zinc binding, 4 as lipid-binding, 4 as iron binding, 3
as transferases,  1 as manganese binding,  1 as oxidoreductases, 1
as carbon-carbon lyases, 1 as carbon-sulfur Lyases, 1 as electro-
chemical potential driven Transporter, 1 as DNA-binding protein
(Supplementary Table 2) . The predicted transmembrane proteins
and transporter protein may be considered as potential drug targets.
The sub cellular localization prediction for the 362 essential pro-
teins of N. meningitides was done by using PA-SUB server to lo-
cate the outer membrane proteins which could be probable vaccine
targets. 9 outer membrane proteins and 10 periplasmic proteins were
identified, which are listed in Supplementary Table 3.
Metabolic pathway analysis of the essential proteins of N. men-
ingitides was done by KEGG Automatic Annotation Server
(KAAS).  Result of comparative analysis of the metabolic path-
ways of the host and pathogen by using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway database reveals 11 path-
ways are unique to N. meningitides serogroup B (supplementary
table 4). Thereafter, each selected pathway was screened for the
presence of pathogen specific essential enzymes. The C5-branched
dibasic acid metabolism pathway did not show involvement of any
meningococcal essential protein. As shown in supplementary table
4, 33 non-human homologous essential proteins identified from
the remaining 10 pathogen specific pathways. This small group of
proteins is required to be further verified for their role in meningo-
coccal survival and virulence by mutagenesis study.
In the present study, phosphoenolpyruvate carboxylase (ppc) has
been identified as a possible drug target due to its involvement in
carbon fixation in photosynthetic organisms, reductive carboxy-
late cycle and pyruvate metabolism.
Lipopolysaccharides (LPS) and peptidoglycans are the main con-
stituents of the outer cell wall of gram negative bacteria and play an
important role in pathogenesis. Out of the thirteen enzymes involved
in LPS biosynthetic pathways, eleven enzymes found to be essen-
tial for the viability of bacteria, were identified as drug targets as
these did not show homology to any human gene. Two proteins
(lipid A biosynthesis lauroyl acyl transferase and D-beta-D-hep-
tose 7-phosphate kinase) are not essential meningococcal enzymes.
Type II secretion pathway supports the translocation of proteins
associated with the virulence factors, across the outer membrane.
Five virulent factors i.e type IV pilus assembly protein (pilF), pilus
assembly protein (pilG), twitching motility protein1 (pilT-1), twitch-
ing motility protein2 (pilT-2), competence protein (comA) are found
to be involved in pathogen specific Type II secretion pathway. Type
IV pilus assembly proteins are the major components in type II
secretion pathway. Type IV pili are associated with bacterial adhe-
sion, aggregation, invasion, host cell signaling, surface motility,
and natural transformation (Rothbard et al., 1985).In this study, it
has been found that type IV pilus assembly protein (PilF) may be
considered for effective anti-meningococcal drug development.
The bacterial two component system is crucial for the growth
and survival under extreme conditions. Eight essential enzymes
found to be potential drug targets in this pathway. Among those
identified enzymes, tryptophan synthase subunit a (trpA), tryptophan
synthase subunit b (trpB), indole-3-glycerol-phosphate synthase
(trpC), anthranilate phosphoribosyltransferase (trpD) and  anthra-
nilate synthase component I (trpE),  are also found to be key com-
ponents in tyrosine, and tryptophan biosynthesis pathways. There-
fore, targeting of these three enzymes may disrupt pathways essen-
tial for N. meningitidis survival and virulence and therefore might
be a potential antibacterial therapeutic strategy.
Thus, further investigations on the predicted essential proteins
are required to verify the reliability of the data. The complete list of
the proteins identified via this in silico approach is available as
supplementary data.
Conclusion
The large scale genome sequencing projects have increased the
availability of completely sequenced genomic and proteomic data
in public domain. Use of the DEG database is more efficient than
conventional methods for identification of essential genes and fa-
cilitates the exploratory identification of the most relevant drug tar-
gets in the pathogen. The present study has thus led to the identifi-
cation of several proteins that can be targeted for effective drug
design and vaccine development against N. meningitides serogroup
B. The drugs developed against these will be specific to the patho-
gen, and therefore less or not toxic to the host. Since the number of
essential genes in the metabolic pathways of N. meningitides
serogroup B, identified in the present study, is relatively small (only
33), these can be further characterized and their role in the survival
of the bacteria can be verified. Homology modelling of these tar-
gets will help identify the best possible sites that can be targeted for
drug design by simulation modelling. Virtual screening against these
novel targets might be useful in the discovery of novel therapeutic
compounds against N. meningitides serogroup B.
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